SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4euu'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DZ4_A_CAMA502_0
(CYTOCHROME P450-CAM)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.13A 1dz4A-4euuA:
undetectable		 1dz4A-4euuA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DZ4_B_CAMB502_0
(CYTOCHROME P450-CAM)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.16A 1dz4B-4euuA:
undetectable		 1dz4B-4euuA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FMO_E_ADNE351_1
(CAMP-DEPENDENT
PROTEIN KINASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
GLY A  16
VAL A  23
ALA A  36
VAL A  68
THR A 156
ASP A 157
 BX7  A 401 (-3.9A)
BX7  A 401 ( 3.8A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
None
IOD  A 402 ( 3.5A)
BX7  A 401 (-3.6A)
 0.65A 1fmoE-4euuA:
26.3		 1fmoE-4euuA:
26.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FMO_E_ADNE351_1
(CAMP-DEPENDENT
PROTEIN KINASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
VAL A  23
ALA A  36
VAL A  68
ASN A 140
THR A 156
ASP A 157
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
None
None
IOD  A 402 ( 3.5A)
BX7  A 401 (-3.6A)
 0.74A 1fmoE-4euuA:
26.3		 1fmoE-4euuA:
26.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IEP_A_STIA201_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 LEU A  15
VAL A  23
ALA A  36
GLU A  55
PHE A  88
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.3A)
 0.60A 1iepA-4euuA:
15.8		 1iepA-4euuA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IEP_B_STIB202_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 LEU A  15
VAL A  23
ALA A  36
GLU A  55
PHE A  88
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.3A)
 0.55A 1iepB-4euuA:
21.3		 1iepB-4euuA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ODI_B_ADNB1237_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 11 ARG A 228
GLY A 139
GLU A 178
ASN A 140
ILE A 141
 None
 1.39A 1odiB-4euuA:
undetectable		 1odiB-4euuA:
24.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OPJ_B_STIB4_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 VAL A  23
ALA A  36
GLU A  55
VAL A  68
PHE A  88
GLY A  92
 BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
None
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.3A)
 0.71A 1opjB-4euuA:
15.4		 1opjB-4euuA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T46_A_STIA3_1
(HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		8 / 12 LEU A  15
VAL A  23
ALA A  36
LYS A  38
GLU A  55
LEU A  59
VAL A  68
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
None
None
BX7  A 401 (-3.3A)
 0.65A 1t46A-4euuA:
16.2		 1t46A-4euuA:
23.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T88_B_CAMB2422_0
(CYTOCHROME P450-CAM)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 5 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.13A 1t88B-4euuA:
undetectable		 1t88B-4euuA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWH_A_BAXA1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 ALA A  36
GLU A  55
LEU A  59
CYH A  89
LEU A 126
HIS A 133
 BX7  A 401 (-3.4A)
None
None
BX7  A 401 (-4.1A)
None
None
 0.64A 1uwhA-4euuA:
13.8		 1uwhA-4euuA:
25.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWH_B_BAXB1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 ALA A  36
LYS A  38
GLU A  55
LEU A  59
CYH A  89
LEU A 126
HIS A 133
 BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
None
BX7  A 401 (-4.1A)
None
None
 0.66A 1uwhB-4euuA:
13.8		 1uwhB-4euuA:
25.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YC2_D_NCAD510_0
(NAD-DEPENDENT
DEACETYLASE 2)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 5 ALA A 161
PHE A 158
ILE A 136
ASP A 203
 None
 1.17A 1yc2D-4euuA:
undetectable		 1yc2D-4euuA:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z11_A_8MOA501_0
(CYTOCHROME P450,
FAMILY 2, SUBFAMILY
A, POLYPEPTIDE 6)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 11 VAL A 280
ILE A 207
GLY A 208
LEU A 277
PHE A 112
 None
 0.88A 1z11A-4euuA:
undetectable		 1z11A-4euuA:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z11_C_8MOC501_0
(CYTOCHROME P450,
FAMILY 2, SUBFAMILY
A, POLYPEPTIDE 6)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 10 VAL A 280
ILE A 207
GLY A 208
LEU A 277
PHE A 112
 None
 0.95A 1z11C-4euuA:
undetectable		 1z11C-4euuA:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z11_D_8MOD501_0
(CYTOCHROME P450,
FAMILY 2, SUBFAMILY
A, POLYPEPTIDE 6)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 10 VAL A 280
ILE A 207
GLY A 208
LEU A 277
PHE A 112
 None
 0.93A 1z11D-4euuA:
undetectable		 1z11D-4euuA:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FEU_A_CAMA1420_0
(CYTOCHROME P450-CAM)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.04A 2feuA-4euuA:
undetectable		 2feuA-4euuA:
22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_B_MIXB1539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
GLY A  16
VAL A  23
ALA A  36
MET A  86
LYS A 137
ASP A 157
 BX7  A 401 (-3.9A)
BX7  A 401 ( 3.8A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.7A)
None
BX7  A 401 (-3.6A)
 0.84A 2fumB-4euuA:
25.8		 2fumB-4euuA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_C_MIXC2539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 LEU A  15
GLY A  16
VAL A  23
ALA A  36
MET A  86
ASN A 140
 BX7  A 401 (-3.9A)
BX7  A 401 ( 3.8A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.7A)
None
 0.79A 2fumC-4euuA:
24.4		 2fumC-4euuA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_D_MIXD3539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
GLY A  16
GLY A  18
VAL A  23
ALA A  36
LYS A 137
MET A 142
 BX7  A 401 (-3.9A)
BX7  A 401 ( 3.8A)
BX7  A 401 (-3.7A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
None
BX7  A 401 (-4.0A)
 0.94A 2fumD-4euuA:
24.3		 2fumD-4euuA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_D_MIXD3539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
GLY A  16
GLY A  18
VAL A  23
ALA A  36
MET A  86
LYS A 137
 BX7  A 401 (-3.9A)
BX7  A 401 ( 3.8A)
BX7  A 401 (-3.7A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.7A)
None
 0.76A 2fumD-4euuA:
24.3		 2fumD-4euuA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HRC_A_CHDA701_0
(FERROCHELATASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 12 MET A 263
LEU A 277
LEU A 269
ILE A 284
SER A 268
 None
 1.22A 2hrcA-4euuA:
undetectable		 2hrcA-4euuA:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_A_STIA600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 LEU A  15
LYS A  38
VAL A  58
VAL A  68
 BX7  A 401 (-3.9A)
BX7  A 401 (-3.5A)
None
None
 0.72A 2hyyA-4euuA:
15.8		 2hyyA-4euuA:
24.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_B_STIB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 LEU A  15
LYS A  38
VAL A  58
VAL A  68
 BX7  A 401 (-3.9A)
BX7  A 401 (-3.5A)
None
None
 0.70A 2hyyB-4euuA:
21.6		 2hyyB-4euuA:
24.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IVU_A_ZD6A3015_0
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET
PRECURSOR)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
GLY A  16
VAL A  23
LYS A  38
GLU A  55
LEU A  59
LEU A  84
 BX7  A 401 (-3.9A)
BX7  A 401 ( 3.8A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.5A)
None
None
None
 0.66A 2ivuA-4euuA:
18.3		 2ivuA-4euuA:
24.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2M56_A_CAMA502_0
(CAMPHOR
5-MONOOXYGENASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 5 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.18A 2m56A-4euuA:
undetectable		 2m56A-4euuA:
21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PNJ_B_CHDB501_0
(FERROCHELATASE,
MITOCHONDRIAL)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 12 MET A 263
LEU A 277
LEU A 269
ILE A 284
SER A 268
 None
 1.21A 2pnjB-4euuA:
undetectable		 2pnjB-4euuA:
22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PO5_A_CHDA501_0
(FERROCHELATASE,
MITOCHONDRIAL)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 12 MET A 263
LEU A 277
LEU A 269
ILE A 284
SER A 268
 None
 1.19A 2po5A-4euuA:
undetectable		 2po5A-4euuA:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AQI_B_CHDB6_0
(FERROCHELATASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 12 MET A 263
LEU A 277
LEU A 269
ILE A 284
SER A 268
 None
 1.03A 3aqiB-4euuA:
undetectable		 3aqiB-4euuA:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3C7Q_A_XINA1172_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
GLY A  16
ALA A  36
LYS A  38
PHE A  88
CYH A  89
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 3.8A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
 0.72A 3c7qA-4euuA:
17.2		 3c7qA-4euuA:
25.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3C7Q_A_XINA1172_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
GLY A  16
ALA A  36
VAL A  68
PHE A  88
CYH A  89
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 3.8A)
BX7  A 401 (-3.4A)
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
 0.41A 3c7qA-4euuA:
17.2		 3c7qA-4euuA:
25.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_A_NILA600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 10 LEU A  15
VAL A  23
LYS A  38
VAL A  68
PHE A  88
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.5A)
None
BX7  A 401 ( 4.6A)
 0.64A 3cs9A-4euuA:
21.4		 3cs9A-4euuA:
24.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_D_NILD600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 12 ALA A  36
GLU A  55
VAL A  58
PHE A  88
GLY A  92
 BX7  A 401 (-3.4A)
None
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.3A)
 0.46A 3cs9D-4euuA:
4.0		 3cs9D-4euuA:
24.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EYG_A_MI1A1_1
(TYROSINE-PROTEIN
KINASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		9 / 12 LEU A  15
GLY A  16
VAL A  23
ALA A  36
LYS A  38
MET A  86
SER A  93
ASN A 140
ASP A 157
 BX7  A 401 (-3.9A)
BX7  A 401 ( 3.8A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
BX7  A 401 (-3.7A)
BX7  A 401 ( 4.7A)
None
BX7  A 401 (-3.6A)
 0.83A 3eygA-4euuA:
16.7		 3eygA-4euuA:
26.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FUP_A_MI1A1_1
(TYROSINE-PROTEIN
KINASE JAK2)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		8 / 12 LEU A  15
GLY A  16
VAL A  23
ALA A  36
LYS A  38
MET A  86
SER A  93
ASP A 157
 BX7  A 401 (-3.9A)
BX7  A 401 ( 3.8A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
BX7  A 401 (-3.7A)
BX7  A 401 ( 4.7A)
BX7  A 401 (-3.6A)
 0.74A 3fupA-4euuA:
14.4		 3fupA-4euuA:
26.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FUP_B_MI1B1_1
(TYROSINE-PROTEIN
KINASE JAK2)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		8 / 12 LEU A  15
GLY A  16
GLY A  18
VAL A  23
ALA A  36
LYS A  38
VAL A  68
MET A  86
 BX7  A 401 (-3.9A)
BX7  A 401 ( 3.8A)
BX7  A 401 (-3.7A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 (-3.7A)
 0.60A 3fupB-4euuA:
16.8		 3fupB-4euuA:
26.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FWF_B_CAMB420_0
(CAMPHOR
5-MONOOXYGENASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 7 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.03A 3fwfB-4euuA:
undetectable		 3fwfB-4euuA:
20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FWG_A_CAMA420_0
(CAMPHOR
5-MONOOXYGENASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.06A 3fwgA-4euuA:
undetectable		 3fwgA-4euuA:
20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G0E_A_B49A9000_1
(MAST/STEM CELL
GROWTH FACTOR
RECEPTOR)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 11 LEU A  15
VAL A  23
ALA A  36
VAL A  68
CYH A  89
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
None
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
 0.29A 3g0eA-4euuA:
2.8		 3g0eA-4euuA:
23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_A_STIA2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 LEU A  15
LYS A  38
VAL A  58
VAL A  68
 BX7  A 401 (-3.9A)
BX7  A 401 (-3.5A)
None
None
 0.70A 3k5vA-4euuA:
15.5		 3k5vA-4euuA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_B_STIB2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 LEU A  15
LYS A  38
VAL A  58
VAL A  68
 BX7  A 401 (-3.9A)
BX7  A 401 (-3.5A)
None
None
 0.66A 3k5vB-4euuA:
20.9		 3k5vB-4euuA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3L63_A_CAMA440_0
(CAMPHOR
5-MONOOXYGENASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 7 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.01A 3l63A-4euuA:
undetectable		 3l63A-4euuA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LFA_A_1N1A361_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 8 ALA A  36
LYS A  38
GLU A  55
LEU A  84
 BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
None
 0.34A 3lfaA-4euuA:
16.5		 3lfaA-4euuA:
26.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LXK_A_MI1A1125_1
(TYROSINE-PROTEIN
KINASE JAK3)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		8 / 12 LEU A  15
GLY A  16
VAL A  23
ALA A  36
LYS A  38
VAL A  68
MET A  86
ASP A 157
 BX7  A 401 (-3.9A)
BX7  A 401 ( 3.8A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 (-3.7A)
BX7  A 401 (-3.6A)
 0.68A 3lxkA-4euuA:
25.4		 3lxkA-4euuA:
24.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MS9_B_STIB1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 LEU A  15
VAL A  23
ALA A  36
GLU A  55
PHE A  88
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.3A)
 0.52A 3ms9B-4euuA:
21.3		 3ms9B-4euuA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_B_STIB1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 LEU A  15
VAL A  23
ALA A  36
GLU A  55
PHE A  88
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.3A)
 0.57A 3mssB-4euuA:
16.0		 3mssB-4euuA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_D_STID1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 VAL A  23
LYS A  38
VAL A  58
VAL A  68
 BX7  A 401 ( 4.6A)
BX7  A 401 (-3.5A)
None
None
 0.62A 3mssD-4euuA:
21.3		 3mssD-4euuA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OCT_A_1N1A663_2
(TYROSINE-PROTEIN
KINASE BTK)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 5 PHE A 158
ILE A  73
ASN A  66
PHE A  56
 None
 1.29A 3octA-4euuA:
21.5		 3octA-4euuA:
24.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OG7_A_032A1_1
(AKAP9-BRAF FUSION
PROTEIN)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 12 VAL A  23
ALA A  36
LYS A  38
LEU A  59
CYH A  89
 BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 (-4.1A)
 0.77A 3og7A-4euuA:
17.2		 3og7A-4euuA:
26.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OHT_B_1N1B1000_1
(P38A)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 GLY A  16
VAL A  23
ALA A  36
LYS A  38
LEU A  59
GLY A  92
 BX7  A 401 ( 3.8A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 (-3.3A)
 0.84A 3ohtB-4euuA:
2.5		 3ohtB-4euuA:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PYY_A_STIA3_1
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 LEU A  15
VAL A  23
ALA A  36
GLU A  55
PHE A  88
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.3A)
 0.77A 3pyyA-4euuA:
21.2		 3pyyA-4euuA:
23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_A_9PLA501_1
(CYTOCHROME P450 2A6)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 11 VAL A 280
ILE A 207
GLY A 208
LEU A 277
PHE A 112
 None
 0.93A 3t3rA-4euuA:
undetectable		 3t3rA-4euuA:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W1W_A_CHDA1502_0
(FERROCHELATASE,
MITOCHONDRIAL)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 12 MET A 263
LEU A 277
LEU A 269
ILE A 284
SER A 268
 None
 1.02A 3w1wA-4euuA:
undetectable		 3w1wA-4euuA:
21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WAR_A_NIOA401_1
(CASEIN KINASE II
SUBUNIT ALPHA)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 8 VAL A  23
LYS A  38
MET A 142
ASP A 157
 BX7  A 401 ( 4.6A)
BX7  A 401 (-3.5A)
BX7  A 401 (-4.0A)
BX7  A 401 (-3.6A)
 0.61A 3warA-4euuA:
16.2		 3warA-4euuA:
24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WRH_E_CAME503_0
(CAMPHOR
5-MONOOXYGENASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.06A 3wrhE-4euuA:
undetectable		 3wrhE-4euuA:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WRJ_E_CAME503_0
(CAMPHOR
5-MONOOXYGENASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.09A 3wrjE-4euuA:
undetectable		 3wrjE-4euuA:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WRL_E_CAME503_0
(CAMPHOR
5-MONOOXYGENASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 7 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.04A 3wrlE-4euuA:
undetectable		 3wrlE-4euuA:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZD_A_LEVA1201_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
VAL A  23
ALA A  36
GLU A  55
LEU A  59
CYH A  89
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
None
None
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
 0.57A 3wzdA-4euuA:
17.3		 3wzdA-4euuA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZE_A_BAXA1201_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		9 / 12 LEU A  15
VAL A  23
ALA A  36
LYS A  38
GLU A  55
LEU A  59
PHE A  88
GLY A  92
LEU A 126
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.3A)
None
 0.49A 3wzeA-4euuA:
22.0		 3wzeA-4euuA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZE_A_BAXA1201_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		9 / 12 LEU A  15
VAL A  23
ALA A  36
LYS A  38
LEU A  59
PHE A  88
GLY A  92
LEU A 126
HIS A 133
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.3A)
None
None
 0.56A 3wzeA-4euuA:
22.0		 3wzeA-4euuA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZOS_A_0LIA1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
ALA A  36
LYS A  38
GLU A  55
LEU A 126
HIS A 133
ARG A 134
 BX7  A 401 (-3.9A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
None
None
SEP  A 172 ( 2.7A)
 0.71A 3zosA-4euuA:
14.0		 3zosA-4euuA:
23.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AG8_A_AXIA2000_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		8 / 12 LEU A  15
VAL A  23
ALA A  36
LYS A  38
GLU A  55
VAL A  68
PHE A  88
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.3A)
 0.53A 4ag8A-4euuA:
22.1		 4ag8A-4euuA:
25.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AGC_A_AXIA2000_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
VAL A  23
ALA A  36
LYS A  38
GLU A  55
LEU A  59
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
None
BX7  A 401 (-3.3A)
 0.43A 4agcA-4euuA:
21.6		 4agcA-4euuA:
24.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AGD_A_B49A2000_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 11 LEU A  15
ALA A  36
VAL A  68
PHE A  88
CYH A  89
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 (-3.4A)
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
 0.41A 4agdA-4euuA:
21.2		 4agdA-4euuA:
24.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ASD_A_BAXA1500_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		10 / 12 LEU A  15
VAL A  23
ALA A  36
LYS A  38
GLU A  55
LEU A  59
PHE A  88
GLY A  92
LEU A 126
HIS A 133
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.3A)
None
None
 0.61A 4asdA-4euuA:
21.8		 4asdA-4euuA:
24.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EK1_A_CAMA502_0
(CAMPHOR
5-MONOOXYGENASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.06A 4ek1A-4euuA:
undetectable		 4ek1A-4euuA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EK1_B_CAMB502_0
(CAMPHOR
5-MONOOXYGENASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 9 THR A 302
LEU A 281
VAL A 280
VAL A 119
VAL A 120
 None
 1.34A 4ek1B-4euuA:
undetectable		 4ek1B-4euuA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4G3R_A_CAMA502_0
(CAMPHOR
5-MONOOXYGENASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.10A 4g3rA-4euuA:
undetectable		 4g3rA-4euuA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4G3R_B_CAMB502_0
(CAMPHOR
5-MONOOXYGENASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.14A 4g3rB-4euuA:
undetectable		 4g3rB-4euuA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I22_A_IREA9001_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		8 / 12 LEU A  15
VAL A  23
ALA A  36
LYS A  38
LEU A  84
MET A  86
GLY A  92
THR A 156
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 (-3.7A)
BX7  A 401 (-3.3A)
IOD  A 402 ( 3.5A)
 0.79A 4i22A-4euuA:
16.2		 4i22A-4euuA:
26.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KKY_X_CAMX503_0
(CAMPHOR
5-MONOOXYGENASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.17A 4kkyX-4euuA:
undetectable		 4kkyX-4euuA:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L49_A_CAMA502_0
(CAMPHOR
5-MONOOXYGENASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 5 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.09A 4l49A-4euuA:
undetectable		 4l49A-4euuA:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L4C_A_CAMA502_0
(CAMPHOR
5-MONOOXYGENASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 PHE A 112
LEU A 281
VAL A 280
VAL A 119
 None
 1.10A 4l4cA-4euuA:
undetectable		 4l4cA-4euuA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OGR_E_ADNE401_1
(CYCLIN-DEPENDENT
KINASE 9)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 7 GLY A  16
ALA A  36
CYH A  89
ASN A 140
ASP A 157
 BX7  A 401 ( 3.8A)
BX7  A 401 (-3.4A)
BX7  A 401 (-4.1A)
None
BX7  A 401 (-3.6A)
 0.83A 4ogrE-4euuA:
19.5		 4ogrE-4euuA:
28.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RZV_B_032B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 VAL A  23
ALA A  36
LYS A  38
CYH A  89
SER A  93
PHE A 158
 BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
BX7  A 401 (-4.1A)
BX7  A 401 ( 4.7A)
None
 1.11A 4rzvB-4euuA:
18.8		 4rzvB-4euuA:
25.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4U0I_A_0LIA1001_2
(MAST/STEM CELL
GROWTH FACTOR
RECEPTOR
KIT,MAST/STEM CELL
GROWTH FACTOR
RECEPTOR KIT)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 ALA A  36
LYS A  38
LEU A  59
CYH A  89
GLY A  92
HIS A 133
 BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
None
 0.60A 4u0iA-4euuA:
21.6		 4u0iA-4euuA:
24.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XV2_A_P06A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 VAL A  23
ALA A  36
LYS A  38
CYH A  89
ASP A 157
PHE A 158
 BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
BX7  A 401 (-4.1A)
BX7  A 401 (-3.6A)
None
 0.69A 4xv2A-4euuA:
17.2		 4xv2A-4euuA:
26.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XV2_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 ALA A  36
LYS A  38
LEU A  59
CYH A  89
ASP A 157
PHE A 158
 BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 (-4.1A)
BX7  A 401 (-3.6A)
None
 0.77A 4xv2B-4euuA:
23.4		 4xv2B-4euuA:
26.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZOW_A_CLMA500_0
(MULTIDRUG
TRANSPORTER MDFA)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 11 LEU A 277
LEU A 269
LEU A 219
LEU A 285
LEU A 281
ILE A 246
 None
 1.35A 4zowA-4euuA:
undetectable		 4zowA-4euuA:
21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AJQ_A_DB8A800_1
(SERINE/THREONINE-PRO
TEIN KINASE 10)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 LEU A  15
ALA A  36
PHE A  88
CYH A  89
GLY A  92
ASP A 157
 BX7  A 401 (-3.9A)
BX7  A 401 (-3.4A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
BX7  A 401 (-3.6A)
 0.75A 5ajqA-4euuA:
17.1		 5ajqA-4euuA:
27.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CSW_A_P06A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 VAL A  23
ALA A  36
LYS A  38
LEU A  59
CYH A  89
PHE A 158
 BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 (-4.1A)
None
 0.73A 5cswA-4euuA:
22.9		 5cswA-4euuA:
26.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CSW_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 VAL A  23
ALA A  36
LYS A  38
LEU A  59
CYH A  89
PHE A 158
 BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 (-4.1A)
None
 0.84A 5cswB-4euuA:
17.4		 5cswB-4euuA:
26.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HI2_A_BAXA801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 ALA A  36
GLU A  55
LEU A  59
CYH A  89
LEU A 126
HIS A 133
 BX7  A 401 (-3.4A)
None
None
BX7  A 401 (-4.1A)
None
None
 0.71A 5hi2A-4euuA:
14.5		 5hi2A-4euuA:
27.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HI2_A_BAXA801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 ALA A  36
LYS A  38
GLU A  55
LEU A  59
CYH A  89
LEU A 126
 BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
None
BX7  A 401 (-4.1A)
None
 0.59A 5hi2A-4euuA:
14.5		 5hi2A-4euuA:
27.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IZJ_G_AZ1G2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
47P-AZ1-DAR-DAR)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 7 GLY A  16
GLY A  18
VAL A  23
LYS A  38
 BX7  A 401 ( 3.8A)
BX7  A 401 (-3.7A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.5A)
 0.32A 5izjA-4euuA:
18.7		 5izjA-4euuA:
26.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5J5X_B_AZ1B2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
47P-AZ1-DAL-DAR-DAR-
DAR-DAR)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 7 GLY A  16
GLY A  18
VAL A  23
LYS A  38
 BX7  A 401 ( 3.8A)
BX7  A 401 (-3.7A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.5A)
 0.42A 5j5xA-4euuA:
19.9		 5j5xA-4euuA:
26.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KKZ_K_ASCK1004_0
(CYTOCHROME B
UBIQUINOL-CYTOCHROME
C REDUCTASE
IRON-SULFUR SUBUNIT)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 7 HIS A 133
ILE A 131
VAL A 132
ARG A  54
 None
None
None
SEP  A 172 ( 3.2A)
 1.12A 5kkzK-4euuA:
undetectable
5kkzQ-4euuA:
undetectable		 5kkzK-4euuA:
21.89
5kkzQ-4euuA:
20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MO4_A_NILA601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 10 LEU A  15
VAL A  23
LYS A  38
GLU A  55
PHE A  88
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.5A)
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.3A)
 0.52A 5mo4A-4euuA:
15.7		 5mo4A-4euuA:
21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N3H_A_NCAA401_0
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 10 LEU A  15
VAL A  23
ALA A  36
VAL A  68
MET A  86
THR A 156
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
None
BX7  A 401 (-3.7A)
IOD  A 402 ( 3.5A)
 0.70A 5n3hA-4euuA:
26.1		 5n3hA-4euuA:
26.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OWR_A_1N1A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 10)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 8 ALA A  36
GLU A  55
CYH A  89
ASP A 157
 BX7  A 401 (-3.4A)
None
BX7  A 401 (-4.1A)
BX7  A 401 (-3.6A)
 0.38A 5owrA-4euuA:
20.1		 5owrA-4euuA:
26.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TE0_A_XINA401_2
(AP2-ASSOCIATED
PROTEIN KINASE 1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 5 LEU A  15
VAL A  23
MET A  86
CYH A  89
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.7A)
BX7  A 401 (-4.1A)
 0.64A 5te0A-4euuA:
24.7		 5te0A-4euuA:
25.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VCV_A_1N1A404_1
(MEMBRANE-ASSOCIATED
TYROSINE- AND
THREONINE-SPECIFIC
CDC2-INHIBITORY
KINASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
ALA A  36
LYS A  38
GLU A  55
VAL A  68
LEU A  84
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
None
None
BX7  A 401 (-3.3A)
 0.92A 5vcvA-4euuA:
23.3		 5vcvA-4euuA:
25.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VCY_A_DB8A401_1
(MEMBRANE-ASSOCIATED
TYROSINE- AND
THREONINE-SPECIFIC
CDC2-INHIBITORY
KINASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		8 / 12 LEU A  15
VAL A  23
ALA A  36
LYS A  38
GLU A  55
LEU A  84
CYH A  89
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
None
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
 1.07A 5vcyA-4euuA:
23.3		 5vcyA-4euuA:
25.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5W5V_A_ANWA701_0
(SERINE/THREONINE-PRO
TEIN KINASE TBK1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		9 / 9 LEU A  15
ALA A  36
VAL A  68
MET A  86
CYH A  89
GLY A  92
THR A  96
MET A 142
THR A 156
 BX7  A 401 (-3.9A)
BX7  A 401 (-3.4A)
None
BX7  A 401 (-3.7A)
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
BX7  A 401 ( 4.5A)
BX7  A 401 (-4.0A)
IOD  A 402 ( 3.5A)
 0.59A 5w5vA-4euuA:
24.0		 5w5vA-4euuA:
56.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7Z_A_IREA401_0
(CYCLIN-G-ASSOCIATED
KINASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
VAL A  23
ALA A  36
LYS A  38
GLU A  55
CYH A  89
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
 0.63A 5y7zA-4euuA:
16.5		 5y7zA-4euuA:
15.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7Z_A_IREA401_0
(CYCLIN-G-ASSOCIATED
KINASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
VAL A  23
ALA A  36
LYS A  38
GLU A  55
CYH A  89
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
 0.63A 5y7zA-4euuA:
16.5		 5y7zA-4euuA:
26.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7Z_B_IREB401_0
(CYCLIN-G-ASSOCIATED
KINASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		8 / 12 LEU A  15
ALA A  36
LYS A  38
GLU A  55
LEU A  84
CYH A  89
GLY A  92
ASP A 157
 BX7  A 401 (-3.9A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
None
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
BX7  A 401 (-3.6A)
 0.72A 5y7zB-4euuA:
10.7		 5y7zB-4euuA:
15.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y80_A_IREA401_0
(CYCLIN-G-ASSOCIATED
KINASE)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		8 / 12 LEU A  15
VAL A  23
ALA A  36
LYS A  38
GLU A  55
CYH A  89
GLY A  92
ASP A 157
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
BX7  A 401 (-3.6A)
 0.60A 5y80A-4euuA:
22.6		 5y80A-4euuA:
15.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZV2_B_LEVB801_1
(FIBROBLAST GROWTH
FACTOR RECEPTOR 1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		6 / 12 LEU A  15
VAL A  23
ALA A  36
LYS A  38
GLU A  55
GLY A  92
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
BX7  A 401 (-3.3A)
 0.29A 5zv2B-4euuA:
21.1		 5zv2B-4euuA:
18.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZWR_A_9KLA402_0
(EST-Y29)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		5 / 12 PHE A 221
ILE A 237
TYR A 212
GLY A 261
ALA A 245
 None
 1.20A 5zwrA-4euuA:
undetectable		 5zwrA-4euuA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_B_STIB602_1
(TYROSINE-PROTEIN
KINASE ABL1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		4 / 6 LEU A  15
VAL A  58
PHE A  88
GLY A  92
 BX7  A 401 (-3.9A)
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.3A)
 0.53A 6hd4B-4euuA:
15.0		 6hd4B-4euuA:
16.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD6_B_STIB601_0
(TYROSINE-PROTEIN
KINASE ABL1)		 4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1
(Homo
sapiens) 		7 / 12 LEU A  15
VAL A  23
ALA A  36
LYS A  38
GLU A  55
VAL A  68
PHE A  88
 BX7  A 401 (-3.9A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
None
None
BX7  A 401 ( 4.6A)
 0.71A 6hd6B-4euuA:
20.8		 6hd6B-4euuA:
16.79